The RIQAS BNP EQA programme is a dedicated programme suitable for use monitoring the performance of B-type Natriuretic Peptide.
Liquid ready-to-use samples requiring minimal preparation

Submit results and view reports online via RIQAS.Net
World's largest EQA scheme ensures peer groups are maximised
Monthly reporting to reduce the risk of errors
Cycle Starts - January 2026
Accredited to ISO17043:2023 standard via RIQAS flexible scope
To find out more about RIQAS EQA or to get in touch with your local Randox Representative, enquire now.
| Description | Frequency | Size | Cat No | |
|---|---|---|---|---|
| BNP | Monthly | 12 x 1 ml | RQ9165 |
Cardiac
Cardiac Plus
General Clinical Chemistry